Verrica Pharmaceuticals Stock
The community is currently still undecided about Verrica Pharmaceuticals with 2 Buy predictions and 0 Sell predictions.
With a target price of 14 € there is potential for a 2309.64% increase which would mean more than doubling the current price of 0.58 € for Verrica Pharmaceuticals.
Our community identified positive and negative aspects for Verrica Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Verrica Pharmaceuticals stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Verrica Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Verrica Pharmaceuticals (NASDAQ:VRCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at TD Cowen from $15.00 to $10.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VRCA provided by MarketBeat